SMAFIRA_Methods  

Documents (644) JSON TSV

source DB source ID text size updated at # proj. # Ann. updated_at
PubMed 21696263 Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hosp 2.59 KB 2019-12-06 8 0
-
PubMed 21635990 Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting. BACKGROUND: 2.86 KB 2019-12-06 5 0
-
PubMed 21218459 Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia. BACKGROUND: Nausea and vomiting in pati 1.88 KB 2019-12-10 5 0
-
PubMed 21188127 Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron. Prevention of nausea and vomiting is the main goal of antiemetic treatment in cancer patients scheduled to recei 1.16 KB 2019-12-10 4 0
-
PubMed 22534864 Antiemetic efficacy of single-dose palonosetron and dexamethasone in patients receiving multiple cycles of multiple day-based chemotherapy. INTRODUCTION: The goal of pharmacological prophylaxis of che 2.06 KB 2019-12-10 5 0
-
PubMed 22823909 Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study. BACKGROUND: 1st generation 5-hydroxytryptamine receptor antagonists (5-HT3 RAs), and pal 2.46 KB 2019-12-06 5 0
-
PubMed 20307224 Review of palonosetron: emerging data distinguishing it as a novel 5-HT(3) receptor antagonist for chemotherapy-induced nausea and vomiting. IMPORTANCE OF THE FIELD: Since the advent of the 5-hydroxyt 1.58 KB 2019-12-10 5 0
-
PubMed 20724484 The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo. Palonosetron is the only 5-HT(3) receptor antagonist approved for the treatment of d 1.95 KB 2019-12-10 5 0
-
PubMed 22970411 Parkinson's disease: leucine-rich repeat kinase 2 and autophagy, intimate enemies. Parkinson's disease is the second common neurodegenerative disorder, after Alzheimer's disease. It is a clinical synd 1.01 KB 2016-01-05 4 0
-
PubMed 22663171 Assessment of the relationship between adherence with antiemetic drug therapy and control of nausea and vomiting in breast cancer patients receiving anthracycline-based chemotherapy. BACKGROUND: There 4.43 KB 2019-12-10 5 0
-